Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MPIF advances to phase II trials in cancer patients

Nov. 19, 1998

First potent, orally active LHRH antagonist discovered by Takeda

Nov. 19, 1998

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Nov. 19, 1998

FDA advisory committee issues positive statement on DepoCyt

Nov. 18, 1998

Novel MMP inhibitor synthesized at Abbott shows potent antitumor activity in vivo

Nov. 18, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

Teijin's new vitamin D derivatives induce cell differentiation

Nov. 17, 1998

IntraBiotics initiates phase II clinical trial for oral mucositis treatment

Nov. 17, 1998

SU-101 may be indicated for combination therapy of prostate cancer

Nov. 17, 1998

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...